Related Stories Scientists discover 70 existing drugs that block deadly hantavirus infections Why new Alzheimers drugs are dividing regulators worldwide Genetic variants may help explain who loses more weight and who gets side effects on GLP-1 drugs Preclinical studies, small controlled trials, and observational research further suggest that GLP-1 receptor agonists may have beneficial effects in the prevention and treatment of mood disorders and in psychopathology domains that substantially impair quality of life, including cognitive dysfunction and anhedonia
Presented for research literature review only Lara-Diaz VJ et al
Lipid exchange at ER-mitochondria contact sites: a puzzle falling into place with quite a few pieces missing
"This is a new strategy for them, which I think will work because there will be a lot of people talking about similar science along with the generic companies, and this will create the overall noise among doctors about their market size," he said
Cloudiness : The solution should always be clear
Lixisenatide The maximum recommended dose of lixisenatide (Lyxumia) is 20 mcg once daily via subcutaneous injection and is licensed for use in people with T2D as monotherapy in those who cannot take metformin or as an add-on treatment to oral agents and/or insulin [31]
